Company Information
CIN
Status
Date of Incorporation
10 May 1985
State / ROC
Mumbai / ROC Mumbai
Last Balance Sheet
31 March 2022
Last Annual Meeting
20 December 2022
Paid Up Capital
40,000,000
Authorised Capital
40,000,000
Directors
Shiraz Bugwadia Homi
Director/Designated Partner
over 2 years ago
over 2 years ago
Vibhuti Krish Raveshia
Director/Designated Partner
over 2 years ago
over 2 years ago
Suresh Hassanand Vazirani
Director/Designated Partner
almost 3 years ago
almost 3 years ago
Mala Suresh Vazirani
Director/Designated Partner
almost 5 years ago
almost 5 years ago
Nikhil Kumar Suresh Vazirani
Director/Designated Partner
about 5 years ago
about 5 years ago
Pavan Choudary
Director
almost 9 years ago
almost 9 years ago
Vivek Gul Asrani
Director/Designated Partner
over 10 years ago
over 10 years ago
Past Directors
Ashok Kumar Pandey
Additional Director
almost 11 years ago
almost 11 years ago
Ravi Hassanand Vazirani
Director
almost 12 years ago
almost 12 years ago
Francis Perikalm Matthew
Director
about 39 years ago
about 39 years ago
Patents
The present invention relates to a solid phase immunoassay kit for detection of target antibodies against M. tuberculosis antigens in a sample selected from one or more patient bodily fluids comprises: a solid support containing immobilized on to it a mixture of mycobacterium specific recombinant protein antigens th...
An reagent system for the direct determination of cholesterol in high density lipoprotein (HDL-C) comprises first reagent comprising a buffer with a pH in the range of 6 to 8, a cholesterol oxidase, a cholesterol esterase, selective surfactant and a phenol based hydrogen donor compound; and second reagent comprising...
A reagent system for the direct determination of cholesterol in high density lipoprotein (HDL-C) comprises first reagent comprising a buffer with a pH in the range of 6 to 8, a cholesterol oxidase, a cholesterol esterase, selective surfactant and a phenol based hydrogen donor compound; and second reagent comprising ...
The invention describes a solid phase immunoassay kit for quantitative estimation of CRP in the human serum and/or plasma samples comprising of:
(a) an insoluble solid support or matrix having multiple microwells that are coated with covalently bonded or physically attached anti-CRP monoclonal antibodies;
(b) a co...
A solid phase immunoassay kit for the detection of IgG and IgM antibodies to M.
tuberculosis proteins in human serum and/or plasma comprises:
(i) solid support containing number of microwells coated with a mixture of antigens containing twelve synthetic peptide antigens of M, tuberculosis;
(ii) IgG conjugated enz...
A serological analysis kit for the detection of IgM antibodies to M. tuberculosis proteins in human serum and/or plasma, which is based on solid phase immunoassay technique comprises:
(iv) a solid support containing number of microwells adsorbed with a mixture of antigens containing twelve synthetic peptide antigen...
A serodiagnostic kit for the detection of IgG antibodies to M. tuberculosis proteins in human serum and/or plasma, which is based on solid phase immunoassay technique comprises:
(iv) a solid support containing number of microwells coated with a mixture of antigens containing twelve synthetic peptide antigens of M t...
According to the principle objects of the present invention, there is provided a solid phase immunoassay kit, which comprises antibodies to HBsAg that are coated on to a solid support and immunochemically acceptable reagents required for detecting said antigens in human serum and/or plasma. Also, provided is a metho...
A rapid diagnostic kit in portable cassette for detecting HIV infection having a absorbent pad paced in square-shape base and a top cover detachably fitted in such manner that the overall cassette is air tight/wherein the top cover has central situated square-shape window in exact confirmation to the that of square-...
A serodiagnostic kit is invented for detecting antibodies to Treponema pallidum proteins in human serum and/or plasma comprises a microplate plate containing multiplicity of microwells, which comprises a mixture of recombinant antigens of T. pallidum; a conjugate, which comprises a mixture of recombinant antigens of...
The present invention relates to a qualitative in vitro diagnostic kit for simultaneous detection of anti-HIV-1 and HIV-2 antibodies, HBsAg and anti-HCV antibodies in human serum and / or plasma comprises: (i) A solid support or matrix with plurality of microwells in which each well is being coated with a mixture of...
A solid phase diagnostic kit for measuring an amount of PRL in human serum
and/or plasma samples comprises:
(i) a microtitre plate having plurality of microwells onto which first group of anti-PRL monoclonal antibodies are coated for separating PRL molecules in the human serum and/or plasma;
(ii) an enzyme conjug...
The present invention relates to a solid phase immunoassay kit for determination of at least one surface antigen (CD4 and/or CD8) comprises a solid support to which one or more monoclonal antibodies (MAb) are fixed by covalent bonding or physical adsorption, which are directed against surface antigens (CD4 and CD8) ...
The instant invention relates to a quantitative detection of substances, particularly antigenic proteins in human serum and/or plasma based on specific solid phase immunoassay techniques. More preferably, the instant invention relates to detection of amount of antigens or hapten like small chemical substances, most ...
The present invention relates to a diagnostic kit for in-vitro detection of Hepatitis C Virus antibodies in the human plasma and serum. More specifically, the subject invention relates to a novel/ diagnostic kit for the detection of antibodies for Hepatitis C Virus in the human serum and plasma. The diagnostic kit o...
The present invention relates to a solid phase immunoassay kit for detection of target antibodies against M. tuberculosis antigens in a sample selected from one or more patient bodily fluids comprise: a solid support containing immobilized on to it a mixture of mycobacterium specific recombinant protein antigens; an...
The invention relates to a kit for quantitatively measuring an amount of 3,5,3,'tri-
iodothyronine (T3) in human serum and/or plasma comprises:(a)a microplate having plurality of microwells, which comprises covalently an anti-T3 monoclonal antibodies to the microwells for precipitating T3 molecules present in the h...
The present invention relates to a solid phase immunoassay kit for the determination of at least one surface antigen (CD4) comprises a solid support to which one or more monoclonal antibodies (MAb) are fixed by covalent bonding or physical adsorption, which are directed against surface antigens (CD4) characteristic ...
The present invention relates to a serological test kit for selectively detecting anti-Dengue-IgM antibodies in human serum and/or plasma comprises coated onto a solid support a mixture of three recombinant Dengue virus antigens for four different types of Dengue virus; and an immunochemically acceptable reagents se...
The present invention relates to a solid phase immunoassays test kit and method for detection of presence of antibodies in a patient to disease-related to antigens of Mycobacterium tuberculosis. A solid phase immunoassay kit for detection of target antibodies against M. tuberculosis antigens in a sample selected fro...
A solid phase diagnostic kit for selectively detecting anti-Dengue-IgG antibodies in human serum and/ or plasma comprises coated onto a solid support a mixture of three recombinant Dengue virus antigens for four different types of Dengue virus; and an immunochemically acceptable reagents selected form an enzyme link...
The present invention relates to an improved and industrial feasible process for the manufacture of copolymer, chemically known as poly(allylamine-co-N,N'-diallyl-l,3-
diamino -2-hydroxypropane hydrochloride.
10 MAY 2006
The present invention relates to quantitative estimation of substances, preferably hormones, in human serum and/or plasma based on specific binding immunoassay techniques. Particularly, it relates to detection of antigens or hapten like small chemical compound, more particularly Follicle Stimulating Hormone, based o...
The present invention relates to an assay kit for measuring a concentration of LH in human serum and/or plasma samples comprises: (a) a microtitre plate, containing plurality of microwells in which anti-LH monoclonal antibodies are coated onto said wells in which covalently bonding for binding with LH molecules pre...
The present invention relates to quantitative measurement of substances, such as hormones, in human serum and/or plasma based on specific binding assay techniques. A diagnostic kit for quantitatively detecting an amount of TSH in human serum and/or plasma samples comprises: (i) a microtitre plate consisting of plura...
The present invention relates to quantitative measurement of substances in human serum and/or plasma, based on specific binding assay techniques. More particularly, it relates to detection of antigens or hapten like small chemical compound based on immunoassay techniques involving the use of labeled reagents, such a...
The present invention relates to immunodiagnosis kit for detecting antibodies to antigens of human immunodeficiency virus (HIV). More particularly, it relates to an immunodiagnosis kit for detecting anti-glycoprotein antigen antibodies of HIV-1 and HIV-2 in human serum and/ or plasma that comprises recombinant glyco...
A diagnostic kit for simultaneously detecting anti-Dengue IgM and IgG antibodies in human serum and/or plasma, in a single assay and in one attempt, comprises an impregnated combination of three recombinant Dengue virus antigens for four different types of Dengue virus with goat anti-human-IgM [u specific] onto a so...
An immunoassay kit for quantitative detection of PSA in human serum
and/or plasma comprises: a solid support as an insoluble matrix comprising number of microwells that are coated with covalently bound or physically adsorbed monoclonal antibodies to PSA; a conjugate comprising number of enzyme labels that are conju...
A diagnostic kit for the screening and detection of antibodies against HIV-1 and/or HIV-2 proteins and HIV-1 p24 antigens in the human serum and plasma comprises:
a. a solid support in which recombinant antigens of HIV-1 and/or HIV-2
and anti-HIV-1 and/or HIV-2 antibodies are coated or adsorbed onto
plurality- of...
The present invention relates to a solid phase immunoassay kit for detection of antibodies to HIV-1 and /or HIV-2 in human blood serum and / or plasma consisting of immunological or serological reagents, such as conjugate, positive control, negative control, signal reagent, sample diluent and washing solution requir...
Registered Trademarks
[Class : 9] Scientific, Research, Measuring, Signalling, Detecting, Testing, Inspecting, Life Saving And Teaching Apparatus And Instruments
[Class : 44] Medical Services
[Class : 37] Installation, Repair And Maintenance Of Medical Devices
View +85 more Brands for Transasia Bio Medicals Limited.
Charges
12 June 2019
The Hongkong And Shanghai Banking Corporation Limited
109 Crore
06 August 2018
The Hongkong And Shanghai Banking Corporation Limited
271 Crore
23 July 2018
The Hongkong And Shanghai Banking Corporation Limited
20 Crore
08 December 2016
Hdfc Bank Limited
36 Crore
15 April 2016
Citi Bank N.a.
423 Crore
07 August 2015
Hdfc Bank Limited
231 Crore
21 May 2014
Citi Bank N.a.
30 Crore
04 July 2013
Kotak Mahindra Bank Limited
40 Crore
05 March 2012
Biotechnology Industry Research Assistance Council
47 Lak
07 September 2007
Hdfc Bank Limited
42 Crore
30 April 2007
The Royal Bank Of Scotland N V
16 Crore
17 June 2017
The Hongkong And Shanghai Banking Corporation Limited
161 Crore
24 January 1988
Indian Bank
33 Lak
16 October 1991
Indian Bank
1 Crore
20 August 1991
Indian Bank
1 Lak
05 August 1994
Union Bank Of India
30 Lak
28 March 2001
Icici Bank Ltd.
5 Crore
18 September 2000
Icici Bank Ltd.
11 Crore
30 May 1996
Indusind Bank
5 Crore
29 October 2009
Barclays Bank Plc
12 Crore
07 August 2003
State Bank Of India
19 Crore
31 August 2007
Ing Vysya Bank Limited
4 Crore
04 May 1999
The Vysya Bank
10 Lak
28 December 1995
The Vysya Bank Ltd.
42 Lak
29 September 1999
The Vysyas Bank Ltd.
2 Crore
15 April 2016
Citi Bank N.a.
0
08 December 2016
Hdfc Bank Limited
0
24 January 1988
Indian Bank
0
07 August 2015
Hdfc Bank Limited
0
21 May 2014
Citi Bank N.a.
0
12 June 2019
The Hongkong And Shanghai Banking Corporation Limited
0
06 August 2018
The Hongkong And Shanghai Banking Corporation Limited
0
23 July 2018
The Hongkong And Shanghai Banking Corporation Limited
0
17 June 2017
The Hongkong And Shanghai Banking Corporation Limited
0
05 August 1994
Union Bank Of India
0
20 August 1991
Indian Bank
0
30 May 1996
Indusind Bank
0
04 July 2013
Kotak Mahindra Bank Limited
0
30 April 2007
The Royal Bank Of Scotland N V
0
07 August 2003
State Bank Of India
0
07 September 2007
Hdfc Bank Limited
0
29 September 1999
The Vysyas Bank Ltd.
0
28 December 1995
The Vysya Bank Ltd.
0
04 May 1999
The Vysya Bank
0
31 August 2007
Ing Vysya Bank Limited
0
16 October 1991
Indian Bank
0
28 March 2001
Icici Bank Ltd.
0
18 September 2000
Icici Bank Ltd.
0
29 October 2009
Barclays Bank Plc
0
05 March 2012
Biotechnology Industry Research Assistance Council
0
15 April 2016
Citi Bank N.a.
0
08 December 2016
Hdfc Bank Limited
0
24 January 1988
Indian Bank
0
07 August 2015
Hdfc Bank Limited
0
21 May 2014
Citi Bank N.a.
0
12 June 2019
The Hongkong And Shanghai Banking Corporation Limited
0
06 August 2018
The Hongkong And Shanghai Banking Corporation Limited
0
23 July 2018
The Hongkong And Shanghai Banking Corporation Limited
0
17 June 2017
The Hongkong And Shanghai Banking Corporation Limited
0
05 August 1994
Union Bank Of India
0
20 August 1991
Indian Bank
0
30 May 1996
Indusind Bank
0
04 July 2013
Kotak Mahindra Bank Limited
0
30 April 2007
The Royal Bank Of Scotland N V
0
07 August 2003
State Bank Of India
0
07 September 2007
Hdfc Bank Limited
0
29 September 1999
The Vysyas Bank Ltd.
0
28 December 1995
The Vysya Bank Ltd.
0
04 May 1999
The Vysya Bank
0
31 August 2007
Ing Vysya Bank Limited
0
16 October 1991
Indian Bank
0
28 March 2001
Icici Bank Ltd.
0
18 September 2000
Icici Bank Ltd.
0
29 October 2009
Barclays Bank Plc
0
05 March 2012
Biotechnology Industry Research Assistance Council
0
15 April 2016
Citi Bank N.a.
0
08 December 2016
Hdfc Bank Limited
0
24 January 1988
Indian Bank
0
07 August 2015
Hdfc Bank Limited
0
21 May 2014
Citi Bank N.a.
0
12 June 2019
The Hongkong And Shanghai Banking Corporation Limited
0
06 August 2018
The Hongkong And Shanghai Banking Corporation Limited
0
23 July 2018
The Hongkong And Shanghai Banking Corporation Limited
0
17 June 2017
The Hongkong And Shanghai Banking Corporation Limited
0
05 August 1994
Union Bank Of India
0
20 August 1991
Indian Bank
0
30 May 1996
Indusind Bank
0
04 July 2013
Kotak Mahindra Bank Limited
0
30 April 2007
The Royal Bank Of Scotland N V
0
07 August 2003
State Bank Of India
0
07 September 2007
Hdfc Bank Limited
0
29 September 1999
The Vysyas Bank Ltd.
0
28 December 1995
The Vysya Bank Ltd.
0
04 May 1999
The Vysya Bank
0
31 August 2007
Ing Vysya Bank Limited
0
16 October 1991
Indian Bank
0
28 March 2001
Icici Bank Ltd.
0
18 September 2000
Icici Bank Ltd.
0
29 October 2009
Barclays Bank Plc
0
05 March 2012
Biotechnology Industry Research Assistance Council
0
Documents
List of share holders, debenture holders;-15122020
Copy of MGT-8-15122020
Form MGT-7-15122020
Form DPT-3-04122020-signed
Form PAS-6-11112020_signed
Optional Attachment-(1)-11112020
Declaration of the appointee director, Managing director, in Form No. DIR-2;-30102020
Form DIR-12-30102020_signed
Evidence of cessation;-30102020
Interest in other entities;-30102020
Optional Attachment-(1)-30102020
Form MSME FORM I-29102020_signed
Optional Attachment-(1)-29092020
Form CHG-1-25092020_signed
Instrument(s) of creation or modification of charge;-24092020
CERTIFICATE OF REGISTRATION FOR MODIFICATION OF CHARGE-20200924
Form DPT-3-10092020-signed
Instrument(s) of creation or modification of charge;-23072020
Optional Attachment-(1)-23072020
Form CHG-1-23072020_signed
CERTIFICATE OF REGISTRATION FOR MODIFICATION OF CHARGE-20200723
Form PAS-6-20072020_signed
Optional Attachment-(1)-20072020
Form PAS-6-15072020_signed
Optional Attachment-(1)-15072020
Form MSME FORM I-30042020_signed
Form ADT-1-18032020_signed
Copy of the intimation sent by company-17032020
Copy of resolution passed by the company-17032020
Copy of written consent given by auditor-17032020
